Cost-Effectiveness Study Comparing Chlorhexidine Bathing With Active Surveillance Cultures to Prevent Methicillin-resistant Staphylococcus Aureus & Other Hospital Infections

Completed · Not applicable

Conditions studied: Staphylococcal Infections

In brief

This pilot study in our medical intensive care unit will evaluate the clinical and cost-effectiveness of an active surveillance program for methicillin-resistant Staphylococcus aureus (MRSA), compared to routine daily bathing with chlorhexidine gluconate (CHG)-impregnated cloths. Outcomes include rate of MRSA acquisition, and of other hospital-acquired infections (e.g., catheter-associated bloodstream infections).

Key facts

Study ID

NCT00779246

Run by

Christiana Care Health Services

People needed

1518

Starts

2008-06-01

Expected to finish

2009-07-01

Last updated by the study team

2018-05-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients admitted to the medical intensive care unit (ICU) are eligible for inclusion

You may not qualify if…

• Patient refusal
• Contraindication to nasal swabbing (arm 1)
• Allergy/sensitivity to chlorhexidine gluconate (CHG) (arm 2)

Where it is running

• Christiana Hospital — Newark, Delaware, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.